Patient Selection for Neoadjuvant Therapy in Early-Stage Pancreatic Cancer

被引：6

作者：

Bergquist, John R. ^{[1
]}

Shubert, Christopher R. ^{[1
]}

Storlie, Curtis B. ^{[1
]}

Habermann, Elizabeth B. ^{[1
]}

Truty, Mark J. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 14期

关键词：

ADJUVANT CHEMOTHERAPY; PROPENSITY; SURVIVAL;

D O I：

10.1200/JCO.2016.71.2315

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1622 / +

页数：3

共 10 条

[1] The use of bootstrapping when using propensity-score matching without replacement: a simulation study [J].

Austin, Peter C. ;

Small, Dylan S. .

STATISTICS IN MEDICINE, 2014, 33 (24) :4306-4319

[2] Doubly robust estimation in missing data and causal inference models [J].

Bang, H .

BIOMETRICS, 2005, 61 (04) :962-972

[3] Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study [J].

Bergquist, John R. ;

Puig, Carlos A. ;

Shubert, Christopher R. ;

Groeschl, Ryan T. ;

Habermann, Elizabeth B. ;

Kendrick, Michael L. ;

Nagorney, David M. ;

Smoot, Rory L. ;

Farnell, Michael B. ;

Truty, Mark J. .

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (01) :52-65

[4] Why the Propensity for Propensity Scores? [J].

Day, Andrew G. .

CRITICAL CARE MEDICINE, 2015, 43 (09) :2024-2026

[5] Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer [J].

Galsky, Matthew D. ;

Stensland, Kristian D. ;

Moshier, Erin ;

Sfakianos, John P. ;

McBride, Russell B. ;

Tsao, Che-Kai ;

Casey, Martin ;

Boffetta, Paolo ;

Oh, William K. ;

Mazumdar, Madhu ;

Wisnivesky, Juan P. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (08) :825-+

[6] Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation [J].

Katz, Matthew H. G. ;

Varadhachary, Gauri R. ;

Fleming, Jason B. ;

Wolff, Robert A. ;

Lee, Jeffrey E. ;

Pisters, Peter W. T. ;

Vauthey, Jean-Nicolas ;

Abdalla, Eddie K. ;

Sun, Charlotte C. ;

Wang, Huamin ;

Crane, Christopher H. ;

Lee, Jeffrey H. ;

Tamm, Eric P. ;

Abbruzzese, James L. ;

Evans, Douglas B. .

ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (07) :1794-1801

[7] Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis [J].

Mokdad, Ali A. ;

Minter, Rebecca M. ;

Zhu, Hong ;

Augustine, Mathew M. ;

Porembka, Matthew R. ;

Wang, Sam C. ;

Yopp, Adam C. ;

Mansour, John C. ;

Choti, Michael A. ;

Polanco, Patricio M. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05) :515-+

[8] Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database [J].

Shubert, Christopher R. ;

Bergquist, John R. ;

Groeschl, Ryan T. ;

Habermann, Elizabeth B. ;

Wilson, Patrick M. ;

Truty, Mark J. ;

Smoot, Rory L. ;

Kendrick, Michael L. ;

Nagorney, David M. ;

Farnell, Michael B. .

SURGERY, 2016, 160 (04) :1080-1093

[9] Propensity matching cannot substitute for randomization in albumin studies [J].

Wiedermann, Christian J. ;

Wiedermann, Wolfgang .

CRITICAL CARE, 2015, 19

[10] Predicting unresectability in pancreatic cancer patients: The additive effects of CT and endoscopic ultrasound [J].

Yovino, Susannah ;

Darwin, Peter ;

Daly, Barry ;

Garofalo, Michael ;

Moesinger, Robert .

JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (01) :36-42

← 1 →